- Investing Ideas
- /
- Taiwanese Pharmaceuticals & Biotech Undervalued based on future growth
Taiwanese Pharmaceuticals & Biotech Undervalued based on future growth
Results
1
0 new
Companies which can be considered undervalued when accounting for expected future growth (PEG under 0.8)
1 companies
| Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | ||
|---|---|---|---|---|---|---|---|---|---|---|
1795 | NT$271.50 | 4.2% | -0.2% | NT$72.0b | NT$398.80 | PE16.6x | E22.3% | 1.7% |
Page 1 of 1